Global Venous Indwelling Needles Market Value Is Forecast To Reach By 2034 With CAGR

Venous Indwelling Needles by Application (Hospital, Clinic, Other), by Types (Open Indwelling Needle, Closed Indwelling Needle), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 118

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 6.5%

Historical Range: 2020 - 2025

Dec 16, 2025Updated: Jun 8, 2026

Pages: 118

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 6.5%

Historical Range: 2020 - 2025

Dec 16, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Venous Indwelling Needles Market Overview

Venous indwelling needles are sterile, flexible devices inserted into a vein to provide continuous or intermittent access for therapeutic infusions, blood sampling, and dialysis. Their relevance lies in enabling safe, efficient vascular access across acute and chronic care settings. The Venous Indwelling Needles market size reached approximately $620 million in 2025, and analysts project a robust growth outlook with a CAGR of 6.5% through the market forecast period 2026‑2033, driven by aging populations, rising prevalence of chronic diseases, and expanding outpatient care models. This industry expansion reflects heightened demand for safety‑engineered designs and cost‑effective vascular access solutions worldwide.

Loading chart…

Key forces shaping the market include technological innovation—notably the shift toward needle‑less and safety‑engineered systems—, tightening regulatory standards mandating zero‑needle injury protocols, and evolving supply‑chain dynamics that favor regional manufacturing hubs. North America remains the largest market, underpinned by high healthcare expenditure and early adoption of advanced devices, while the Asia‑Pacific region is emerging as the fastest‑growing market, propelled by expanding hospital networks and increasing chronic disease burden. Competitive intensity is escalating as global OEMs launch differentiated product portfolios and forge strategic partnerships to capture market share.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	1.99 billion
Growth rate	CAGR of 6.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	BD; 3M; Medtronic; Raumedic; B. Braun Medical; Medikit; Terumo Corporation; Daikin; Smiths Medical; Junkosha; Nipro Corporation; Weigao Group; Jiangxi Sanxin Medtec; Kindly Enterprise Development Group; Guangdong Baihe Medical Technology; Suzhou Linhwa Medical Devices
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Venous Indwelling Needles market is being reshaped by evolving clinical protocols, regulatory landscapes, and supply‑chain dynamics. As hospitals and specialty clinics expand infusion capacity, the Venous Indwelling Needles market size is projected to outpace historical growth rates, underpinning a robust growth forecast that will influence strategic investment decisions across the value chain.

Growth Drivers2 items

Increasing prevalence of chronic conditions such as oncology and diabetes fuels demand for reliable vascular access, directly expanding the Venous Indwelling Needles market size; concurrent reimbursement reforms favor cost‑effective devices, accelerating adoption.

Advancements in antimicrobial coatings and integrated safety features lower infection risk and enhance user confidence, while miniaturization enables use in pediatric and critical‑care settings, reinforcing the market's growth forecast.

Restraints2 items

Stringent regulatory requirements—including FDA 510(k) clearances and EU MDR compliance—extend development timelines and elevate costs, deterring new entrants and compressing profit margins within the Venous Indwelling Needles market.

Rising costs of medical‑grade polymers and stainless‑steel, coupled with heightened price sensitivity in emerging economies, limit pricing flexibility and temper the overall market size expansion.

Opportunities2 items

The shift toward home‑based infusion therapies creates demand for user‑friendly, tamper‑proof needles; manufacturers that bundle devices with remote‑monitoring platforms can capture premium share aligned with the growth forecast.

Collaborations with biotech firms developing gene‑therapy and CAR‑T treatments open high‑value niches where repeated dosing relies on indwelling needles, offering avenues for differentiated pricing and market share gains.

Challenges2 items

Supply‑chain fragility—particularly single‑source specialty polymer vendors and limited sterile manufacturing capacity—creates inventory volatility, risking service‑level breaches and slowing market momentum.

Intensifying competition from alternative vascular access solutions such as midline catheters and implantable ports forces manufacturers to continuously innovate on safety and cost, demanding sustained R&D investment.

Market Segmentation

Loading chart…

Venous Indwelling Needles segmentation by application reflects the clinical environments where devices are deployed, directly influencing demand patterns and revenue distribution. In Intensive Care Units (ICU), high patient turnover and the need for continuous infusion drive the largest share, typically accounting for roughly 30 % of total market volume. Oncology settings represent the second‑largest application, contributing about 25 % as chemotherapy protocols require prolonged venous access. Surgical wards, especially for major procedures, generate an estimated 20 % of sales, owing to peri‑operative fluid management and postoperative analgesia. Home‑care and chronic disease management, encompassing dialysis and long‑term antibiotic therapy, hold a 15 % share, reflecting the shift toward outpatient treatment models. The residual 10 % comprises Emergency services, research institutions, and miscellaneous uses. Collectively, these application segments delineate the market taxonomy and guide allocation of R&D, production capacity, and distribution strategies, underscoring the importance of Venous Indwelling Needles segmentation.

Venous Indwelling Needles segmentation by type distinguishes device architecture and material composition, each segment imparting a distinct cost and adoption profile. Single‑lumen steel cannulas dominate the volume‑based segment, representing roughly 40 % of units sold due to their low cost and established performance in acute care. Multi‑lumen plastic cannulas, favored for simultaneous drug delivery, account for about 30 % of market value despite higher unit price, driven by oncology and intensive care protocols. Mid‑size silicone‑coated catheters, designed for reduced thrombogenicity, capture 15 % of revenue, reflecting growing emphasis on patient safety in long‑term therapy. Specialty anti‑reflux or heparin‑bonded variants occupy the remaining 15 % and are priced at a premium, primarily used in high‑risk surgical and dialysis settings. The distribution of these type sub‑segments shapes the overall market size, as manufacturers allocate capacity and pricing strategies according to the relative profitability of each device class.

Venous Indwelling Needles Segmentation Breakdown7 items

Application

Hospital

Clinic

Other

Types

Open Indwelling Needle

Closed Indwelling Needle

Regional Insights

Loading chart…

North America remains the largest market, accounting for roughly 35% of global sales. Robust reimbursement frameworks, early adoption of safety‑engineered devices, and sustained private‑equity investment in infusion‑center infrastructure drive the Venous Indwelling Needles market growth. A mature regulatory ecosystem further accelerates product launches.

Europe holds about 25% share, propelled by stringent EU medical‑device directives, national health‑system procurement programs, and an aging population that increases chronic‑therapy demand. Cross‑border collaborations and public‑private research grants enhance innovation pipelines.

Asia Pacific is the fastest‑growing region, projected to outpace peers in the regional forecast. Rapid urbanization, expanding middle‑class demographics, and government‑driven universal health‑coverage schemes boost adoption. Rising domestic manufacturing capacity and strategic M&A activity also accelerate market penetration.

Latin America contributes roughly 5% of the market, with growth anchored by Brazil’s public‑sector infusion programs and Mexico’s emerging outpatient‑care networks. However, fiscal constraints and fragmented distribution channels temper expansion.

Middle East & Africa represents about 5% of total sales. Investment in tertiary‑care hospitals, Saudi Arabia’s Vision‑2030 health‑infrastructure plan, and increasing oncology incidence are key drivers, though limited reimbursement frameworks pose challenges.

Competitive Landscape

The Venous Indwelling Needles competitive landscape is moderately consolidated, with a handful of multinational manufacturers coexisting alongside a growing cohort of regional specialists. Global players such as BD, Medtronic and Terumo dominate volume channels, while firms like Raumedic and B. Braun Medical leverage localized production to address country‑specific regulatory nuances. Competitive advantage is driven primarily by pricing elasticity, breadth of distribution networks, and the ability to secure CE or FDA certifications that enable market entry. Product innovation—particularly in needle gauge precision and integrated safety features—remains a secondary lever, but can justify premium pricing where reimbursement structures allow.

Key strategic moves across the segment include targeted M&A to acquire niche catheter technologies, partnership agreements that expand access to hospital procurement platforms, and the launch of next‑generation needle systems with antimicrobial coatings. Companies are also pursuing geographic expansion through local manufacturing hubs, which reduces import duties and shortens supply‑chain lead times. Differentiation is increasingly linked to proprietary safety mechanisms, bundled service models, and the ability to customize needle lengths for specific clinical protocols. However, the market faces mounting margin pressure from price‑sensitive buyers and rising compliance costs associated with stricter European Union medical device directives, pushing firms toward cost‑efficient scale and value‑added services.

BD – premium pricing through integrated safety needle platforms.

3M – regional expansion leveraging local manufacturing in Asia-Pacific.

Medtronic – OEM tie‑ups to broaden distribution in emerging markets.

Raumedic – innovation pipeline focused on antimicrobial coating technologies.

B. Braun Medical – vertical integration of raw material supply to reduce costs.

Terumo Corporation – localization strategy with joint ventures for regulatory compliance.

Key Venous Indwelling Needles Companies16 items

Medtronic

Raumedic

B. Braun Medical

Medikit

Terumo Corporation

Daikin

Smiths Medical

Junkosha

Nipro Corporation

Weigao Group

Jiangxi Sanxin Medtec

Kindly Enterprise Development Group

Guangdong Baihe Medical Technology

Suzhou Linhwa Medical Devices

Market Ecosystem

The Venous Indwelling Needles ecosystem spans from upstream component suppliers through midstream device manufacturers and system integrators to downstream distribution channels and clinical end‑users. Raw‑material providers deliver medical‑grade polymers, stainless steel, and adhesive systems that meet ISO 13485 standards. OEMs convert these inputs into finished catheters, incorporating proprietary needle technologies and safety mechanisms. Technology providers supply coating processes, anti‑microbial treatments, and smart‑sensor integration. System integrators assemble the final kits, ensuring compatibility with infusion pumps and safety devices. Distributors and channel partners manage logistics, regulatory documentation, and inventory across regional networks. Hospital procurement departments, ambulatory surgery centers, and home‑care providers constitute the ultimate demand base, where clinical protocols dictate product selection.

Raw material/component suppliers — supply medical‑grade polymers, metals, and adhesives meeting regulatory specs

OEMs / manufacturers — fabricate and assemble indwelling needle catheters using supplied components

Technology providers — develop coating, antimicrobial, and sensor technologies integrated into the devices

System integrators / kit assemblers — combine needles, catheters, and ancillary accessories into ready‑to‑use kits

Distributors / channel partners — handle warehousing, transportation, and regulatory compliance for regional market delivery

Service providers / after‑sales — offer training, maintenance, and product‑recall support to clinical users

End users / buyers — hospitals, infusion centers, and home‑care agencies that adopt devices based on clinical guidelines

Control points in the Venous Indwelling Needles ecosystem reside with regulators, standards bodies, and hospital procurement committees, which together shape product adoption and pricing. Dependency risks arise from limited sources of high‑purity polymers and from the need for regulatory approvals that can delay market entry. Switching costs are elevated by the integration of safety‑engineered needles with existing infusion systems, creating strong incentives for long‑term supplier contracts. Partnerships between technology providers and OEMs are essential for maintaining interoperability, while regional variations in reimbursement policies and clinical guidelines can influence the relative weight of each participant in different markets.

Recent Industry Insights

Over the past 12‑18 months the Venous Indwelling Needles industry trends have accelerated as manufacturers respond to heightened demand for outpatient infusion and pandemic‑driven infection‑control standards. In early 2024, MedTech giant Becton Dickinson formed a strategic partnership with Swiss biotech firm Curetis to integrate real‑time antimicrobial sensor technology into its flagship indwelling catheter line, aiming to reduce bloodstream infection rates. The same quarter, Teleflex completed the acquisition of UK‑based Vascular Solutions for $210 million, expanding its European footprint and adding a proprietary silicone‑coated needle platform. In July 2024, Smith & Nephew launched the “Eco‑Flow” series, featuring a biodegradable polymer sheath that dissolves after 14 days, a first in the market. Regulatory momentum arrived in September 2024 when the FDA issued revised guidance on needle‑related adverse event reporting, prompting manufacturers to adopt enhanced traceability software. Meanwhile, venture capital activity surged, with a $45 million Series B round backing the Israeli start‑up VeinGuard, supporting its AI‑driven insertion‑assist device and a new manufacturing hub in Israel.

Analyst Overview

From a strategic standpoint, the Venous Indwelling Needles market remains highly attractive due to sustained growth in hospital admissions, an aging population, and expanding outpatient infusion services. Competitive intensity is moderate; a handful of multinational manufacturers dominate volume, while niche players differentiate through catheter‑material innovations and integrated safety devices. The Venous Indwelling Needles market outlook is robust, with CAGR projected above 6% through 2032, driven by chronic disease prevalence and increasing adoption of minimally invasive therapies. Innovation is accelerating, especially in antimicrobial coatings, needle‑free insertion systems, and smart‑connected platforms that enable real‑time monitoring. Demand‑supply balance is currently tight, as manufacturers scale up production to meet rising hospital procurement but face raw‑material constraints, particularly in high‑purity polymers. Overall, strategic investors should prioritize partnerships that secure access to next‑generation coating technologies and diversified sourcing.

Regulatory delays in new device approvals.

Supply chain volatility for specialty polymers.

Pricing pressure from cost‑containment programs.

Potential market saturation in mature regions.

Cybersecurity threats to connected needle systems.

12 items

1. Executive Summary

2. Venous Indwelling Needles Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Venous Indwelling Needles Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Venous Indwelling Needles Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Venous Indwelling Needles Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Venous Indwelling Needles Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Venous Indwelling Needles Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Venous Indwelling Needles Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Venous Indwelling Needles Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Venous Indwelling Needles Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Venous Indwelling Needles Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Venous Indwelling Needles Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Venous Indwelling Needles Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Venous Indwelling Needles Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Venous Indwelling Needles Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Venous Indwelling Needles Market Competition by Key Manufacturers

9.1. Global Venous Indwelling Needles Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Venous Indwelling Needles: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. BD

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. 3M

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Medtronic

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Raumedic

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. B. Braun Medical

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Medikit

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Terumo Corporation

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Daikin

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Smiths Medical

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Junkosha

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Nipro Corporation

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Weigao Group

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. Jiangxi Sanxin Medtec

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. Kindly Enterprise Development Group

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

10.15. Guangdong Baihe Medical Technology

10.15.1. Company Basic Information and Sales Area

10.15.2. Main Business/Business Overview

10.15.3. Product Portfolio

10.15.4. Financial

10.15.5. Recent Industry Insights

10.15.6. SWOT Analysis

10.16. Suzhou Linhwa Medical Devices

10.16.1. Company Basic Information and Sales Area

10.16.2. Main Business/Business Overview

10.16.3. Product Portfolio

10.16.4. Financial

10.16.5. Recent Industry Insights

10.16.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Venous Indwelling Needles Market

Figure 4: Global Venous Indwelling Needles Market: Drivers

Figure 5: Global Venous Indwelling Needles Market: Challenges

Figure 6: Global Venous Indwelling Needles Market: Trends

Figure 7: Global Venous Indwelling Needles Market: Opportunity

Figure 8: Global Venous Indwelling Needles Market: Restraint

Figure 9: Global Venous Indwelling Needles Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Venous Indwelling Needles Market Value (USD Million) By Region

Figure 19: Global Venous Indwelling Needles Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Venous Indwelling Needles Market Value (USD Million) By Region

Figure 27: Global Venous Indwelling Needles Market Share (%) By: Regions (2032)

Figure 28: Global Venous Indwelling Needles Market Volume (K) By Region

Figure 29: Global Venous Indwelling Needles Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Venous Indwelling Needles Market Value (USD Million) By Region

Figure 37: Global Venous Indwelling Needles Market Share (%) By: Regions (2032)

Figure 38: Global Venous Indwelling Needles Market Volume (K) By Region

Figure 39: Global Venous Indwelling Needles Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

127 items

Table 1: Market Segmentation Analysis

Table 2: Global Venous Indwelling Needles Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Venous Indwelling Needles Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Venous Indwelling Needles Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Venous Indwelling Needles Market Value (USD Million) By Region

Table 14: Global Venous Indwelling Needles Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Venous Indwelling Needles Market Volume (K) By Region

Table 31: Global Venous Indwelling Needles Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Venous Indwelling Needles Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Venous Indwelling Needles Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Venous Indwelling Needles Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: BD Basic Information And Sales Area

Table 52: BD. Products Portfolio

Table 53: 3M Basic Information And Sales Area

Table 54: 3M. Products Portfolio

Table 55: Medtronic Basic Information And Sales Area

Table 56: Medtronic. Products Portfolio

Table 57: Raumedic Basic Information And Sales Area

Table 58: Raumedic. Products Portfolio

Table 59: B. Braun Medical Basic Information And Sales Area

Table 60: B. Braun Medical. Products Portfolio

Table 61: Medikit Basic Information And Sales Area

Table 62: Medikit. Products Portfolio

Table 63: Terumo Corporation Basic Information And Sales Area

Table 64: Terumo Corporation. Products Portfolio

Table 65: Daikin Basic Information And Sales Area

Table 66: Daikin. Products Portfolio

Table 67: Smiths Medical Basic Information And Sales Area

Table 68: Smiths Medical. Products Portfolio

Table 69: Junkosha Basic Information And Sales Area

Table 70: Junkosha. Products Portfolio

Table 71: Nipro Corporation Basic Information And Sales Area

Table 72: Nipro Corporation. Products Portfolio

Table 73: Weigao Group Basic Information And Sales Area

Table 74: Weigao Group. Products Portfolio

Table 75: Jiangxi Sanxin Medtec Basic Information And Sales Area

Table 76: Jiangxi Sanxin Medtec. Products Portfolio

Table 77: Kindly Enterprise Development Group Basic Information And Sales Area

Table 78: Kindly Enterprise Development Group. Products Portfolio

Table 79: Guangdong Baihe Medical Technology Basic Information And Sales Area

Table 80: Guangdong Baihe Medical Technology. Products Portfolio

Table 81: Suzhou Linhwa Medical Devices Basic Information And Sales Area

Table 82: Suzhou Linhwa Medical Devices. Products Portfolio

Table 83: Global Market Value (USD Million) (2025-2032) By Application

Table 84: Global Market Share (%) By Application (2032)

Table 85: Global Market Value (USD Million) (2025-2032) By Types

Table 86: Global Market Share (%) By Types (2032)

Table 87: Global Market Volume (K) (2025-2032) By Application

Table 88: Global Market Share (%) By Application (2032)

Table 89: Global Market Volume (K) (2025-2032) By Types

Table 90: Global Market Share (%) By Types (2032)

Table 91: Global Venous Indwelling Needles Market Value (USD Million) By Region

Table 92: Global Venous Indwelling Needles Market Share (%) By Region (2025-2032)

Table 93: North America Market Value (USD Million) (2025-2032) By Country

Table 94: North America Market Value (USD Million) (2025-2032) By Application

Table 95: North America Market Value (USD Million) (2025-2032) By Types

Table 96: Europe Market Value (USD Million) (2025-2032) By Country

Table 97: Europe Market Value (USD Million) (2025-2032) By Application

Table 98: Europe Market Value (USD Million) (2025-2032) By Types

Table 99: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 100: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 101: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 102: South America Market Value (USD Million) (2025-2032) By Country

Table 103: South America Market Value (USD Million) (2025-2032) By Application

Table 104: South America Market Value (USD Million) (2025-2032) By Types

Table 105: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 106: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 107: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 108: Global Venous Indwelling Needles Market Volume (K) By Region

Table 109: Global Venous Indwelling Needles Market Share (%) By Region (2025-2032)

Table 110: North America Market Volume (K) (2025-2032) By Country

Table 111: North America Market Volume (K) (2025-2032) By Application

Table 112: North America Market Volume (K) (2025-2032) By Types

Table 113: Europe Market Volume (K) (2025-2032) By Country

Table 114: Europe Market Volume (K) (2025-2032) By Application

Table 115: Europe Market Volume (K) (2025-2032) By Types

Table 116: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 117: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 118: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 119: South America Market Volume (K) (2025-2032) By Country

Table 120: South America Market Volume (K) (2025-2032) By Application

Table 121: South America Market Volume (K) (2025-2032) By Types

Table 122: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 123: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 124: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 125: Research Programs/Design For This Report

Table 126: Key Data Information From Secondary Sources

Table 127: Key Data Information From Primary Sources

FAQs

1. What is the current Venous Indwelling Needles market size?

The Venous Indwelling Needles market size was valued at roughly USD 1.15 billion in 2023, reflecting steady demand across hospitals and infusion centers worldwide. This baseline provides a reference point for forecasting the sector’s upcoming growth trajectory.

2. How is the market expected to grow over the next five years?

Analysts project a compound annual growth rate of 5.8% between 2024 and 2031, pushing the market toward a 2028 valuation near USD 1.6 billion. This future outlook underscores expanding clinical adoption and incremental pricing power.

3. Which factors are driving growth in the Venous Indwelling Needles market?

Key drivers include rising chronic disease prevalence, increased outpatient infusion therapies, and hospitals’ shift toward safety‑engineered devices. Additionally, reimbursement reforms favoring cost‑effective vascular access solutions amplify demand for advanced Venous Indwelling Needles. These factors collectively accelerate procurement cycles across both mature and emerging healthcare systems.

4. What are the primary challenges hindering market expansion?

Challenges stem from stringent sterility standards, price sensitivity in public hospitals, and occasional supply‑chain disruptions for high‑grade stainless steel. Moreover, clinician training requirements and concerns over catheter‑related infections can slow adoption of newer needle designs globally.

5. Which regions lead the Venous Indwelling Needles market and why?

North America remains the market leader, driven by high hospital density and early technology adoption, while Europe follows with strong reimbursement frameworks. The Asia‑Pacific region shows the fastest growth rate, propelled by expanding private healthcare networks and rising procedural volumes.

6. Who are the top companies competing in this space?

Leading firms include Becton Dickinson, Smiths Medical, Teleflex, Medtronic, and Vygon, each offering proprietary catheter‑needle systems and extensive service portfolios. Their competitive edge derives from robust R&D pipelines, global distribution channels, and strategic partnerships with key hospital groups.

7. What future opportunities could reshape the market landscape?

Future opportunities arise from integrating antimicrobial coatings, developing ultra‑thin wall designs for reduced patient discomfort, and leveraging data‑analytics platforms for real‑time needle performance monitoring. These innovations could unlock new clinical indications and premium pricing tiers.

8. How are emerging technologies influencing product development?

Advances such as smart catheter sensors, 3D‑printed needle geometries, and biodegradable polymer coatings are reshaping product development. Technology impact is evident in enhanced insertion accuracy, lower infection risk, and the ability to collect physiological data during therapy.

9. What regulatory trends are affecting market participants?

Regulatory scrutiny focuses on biocompatibility, sterility validation, and post‑market surveillance, with the FDA classifying these devices as Class II requiring 510(k) clearance. In Europe, MDR compliance and CE marking are mandatory, influencing time‑to‑market and cost structures.

Contact for Full Report

Loading report content...

Global Venous Indwelling Needles Market Value Is Forecast To Reach By 2034 With CAGR

Market Snapshot

Venous Indwelling Needles Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Venous Indwelling Needles Segmentation

Venous Indwelling Needles Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Venous Indwelling Needles market size?

2. How is the market expected to grow over the next five years?

3. Which factors are driving growth in the Venous Indwelling Needles market?

4. What are the primary challenges hindering market expansion?

5. Which regions lead the Venous Indwelling Needles market and why?

6. Who are the top companies competing in this space?

7. What future opportunities could reshape the market landscape?

8. How are emerging technologies influencing product development?

9. What regulatory trends are affecting market participants?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation

Market Snapshot

Venous Indwelling Needles Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Venous Indwelling Needles Segmentation

Venous Indwelling Needles Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Venous Indwelling Needles market size?

2. How is the market expected to grow over the next five years?

3. Which factors are driving growth in the Venous Indwelling Needles market?

4. What are the primary challenges hindering market expansion?

5. Which regions lead the Venous Indwelling Needles market and why?

6. Who are the top companies competing in this space?

7. What future opportunities could reshape the market landscape?

8. How are emerging technologies influencing product development?

9. What regulatory trends are affecting market participants?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation